Tech Company Financing Transactions

Ten63 Therapeutics Funding Round

Hatteras Venture Partners, Alexandria Venture Investments and Draper Associates participated in a $15.9 million Series A capital raise for Ten63 Therapeutics. The financing round was announced on 5/2/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Durham Fwy
Durham, NC Undisclosed
USA

Phone

Undisclosed

Website

www.ten63tx.com

Email Address

[email protected]

Overview

Ten63 is pushing the boundaries of computational drug discovery to design first and best-in-class therapeutics with enhanced durability against previously undruggable targets. Our BEYOND platform allow us to design potent chemistry against the hardest targets by searching previously unexplored, drug-like, synthetically accessible chemical space.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Bruce Donald

        

Chief Executive Officer

Marcel Frenkel

        

Chief Technical Officer

Mark Hallen

        

Co-Founder

Nancy Rich

        

Browse more venture capital transactions:

Prev: 5/2/2023: Essenvia venture capital transaction
Next: 5/2/2023: Tangem venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary